Success Story: NIW Approval for an Organic Chemistry Scientist From Vietnam Advancing Safer Drug Manufacturing
Client’s Testimonial:
"Thank you for your help."
On July 16th, 2026, we received another EB-2 NIW (National Interest Waiver) approval for a Senior Principal Scientist in the Field of Organic Chemistry (Approval Notice).
General Field: Organic Chemistry
Position at the Time of Case Filing: Senior Principal Scientist
Country of Origin: Vietnam
State of Residence at the Time of Filing: Indiana
Approval Notice Date: July 16th, 2026
Processing Time: 2 months, 19 days (Premium Processing Requested)
Case Summary:
Many of today's most important medicines depend on manufacturing processes that must balance efficiency, safety, cost, and environmental responsibility. Even small improvements in chemical synthesis can strengthen pharmaceutical production, reduce manufacturing risks, and make critical therapies more accessible. The client's work contributes to these objectives by developing safer synthetic methods for critical therapeutic candidates while improving the efficiency and reliability of large-scale pharmaceutical and chemical manufacturing.
North America Immigration Law Group (Chen Immigration Law Associates) prepared the NIW petition by demonstrating that the client's work addressed issues extending far beyond a single employer. We explained how the client's research supported safer reaction design, reduced dependence on hazardous transition-metal catalysts, and evaluated alternative manufacturing approaches that could improve the production of medicines used to treat viral infections, diabetes, and obesity. These advances also aligned with national priorities involving pharmaceutical resilience, biotechnology, and sustainable manufacturing.
To demonstrate that the client was well positioned to continue advancing this work, we documented a combination of academic, industrial, and scholarly accomplishments, including:
- Ph.D. in Chemistry.
- 3 peer-reviewed journal articles
- Research cited 14 times by independent researchers.
- Research supported by funding from the National Institute of General Medical Sciences (NIGMS), the National Institutes of Health (NIH), and the National Science Foundation (NSF).
The petition also showed that the client's work had already influenced subsequent research in organic synthesis. Independent investigators built upon the client's mechanistic studies to better understand reaction selectivity, stereochemical control, and synthetic reaction pathways. These examples demonstrated that the client's findings were serving as a foundation for additional scientific advances while supporting the development of safer and more efficient pharmaceutical manufacturing processes.
This approval reflects the importance of improving the chemistry behind modern medicines, not only by discovering new compounds, but by making their production safer, more reliable, and more sustainable. We were proud to help present the client's qualifications and demonstrate how this work can continue benefiting pharmaceutical innovation and public health in the United States.